<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="04/05/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9764907" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9764907</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Potent inhibition of <term sem="Other" id="T1" lex="HIV_type_1_replication"><term sem="Virus" id="T2" lex="HIV_type_1">HIV type 1</term> replication</term> by an <term sem="Organic_compound_other" id="T3" lex="antiinflammatory_alkaloid">antiinflammatory alkaloid</term>, <term sem="Organic_compound_other" id="T4" lex="cepharanthine">cepharanthine</term>, in <term sem="Cell_natural" id="T5" lex="chronically_infected_monocytic_cell">chronically infected monocytic cells</term>.</sentence>
<event id="E1">
<type class="Viral_life_cycle" />
<theme idref="T2" />
<clue>Potent inhibition of HIV type 1 <clueType>replication</clueType> by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E1" />
<cause idref="T4" />
<clue>Potent <clueType>inhibition</clueType> <linkTheme>of</linkTheme> HIV type 1 replication <linkCause>by</linkCause> an antiinflammatory alkaloid, cepharanthine, <clueLoc>in chronically infected monocytic cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Organic_compound_other" id="T6" lex="cepharanthine">Cepharanthine</term> is a <term sem="Organic_compound_other" id="T7" lex="biscoclaurine_alkaloid">biscoclaurine alkaloid</term> isolated from <term sem="Multicellular_organism_natural" id="T8" lex="Stephania_cepharantha_Hayata">Stephania cepharantha Hayata</term> and has been shown to have antiinflammatory, antiallergic, and immunomodulatory activities in vivo.</sentence>
<sentence id="S3">As several <term sem="Protein_family_or_group" id="T9" lex="inflammatory_cytokine">inflammatory <term sem="Protein_family_or_group" id="T10" lex="cytokine">cytokines</term></term> and <term sem="Other" id="A2">oxidative stresses</term> are involved in the <term sem="Other" id="A12">pathogenesis</term> of <term sem="Other" id="T11" lex="HIV-1_infection"><term sem="Virus" id="A1">HIV-1</term> infection</term>, we investigated the inhibitory effects of <term sem="Organic_compound_other" id="T12" lex="cepharanthine">cepharanthine</term> on <cons sem="(AND Other Other)" id="T13" lex="(AND tumor_necrosis_factor_alpha_(TNF-alpha)-induced_HIV-1_replication phorbol_12-myristate_13-acetate_(PMA)-induced_HIV-1_replication)"><frag id="F1">tumor necrosis factor alpha (<term sem="Protein_molecule" id="T14" lex="TNF-alpha">TNF-alpha</term>)-</frag> and <frag id="F2">phorbol 12-myristate 13-acetate (<term sem="Organic_compound_other" id="T15" lex="PMA">PMA</term>)-</frag><frag id="F3">induced <term sem="Virus" id="A3">HIV-1</term> replication</frag></cons> in <term sem="Cell_cultured" id="T16" lex="chronically_infected_cell_line">chronically infected cell lines</term>.</sentence>
<event id="E3">
<type class="Initiation_of_viral_infection" />
<theme idref="A1" />
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 <clueType>infection</clueType>, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event id="E4">
<type class="Regulation" />
<theme idref="A12" />
<cause idref="T9" />
<clue>As several inflammatory cytokines and oxidative stresses are <clueType>involved</clueType> <linkTheme>in</linkTheme> the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event id="E40">
<type />
<theme idref="E3" />
<clue>As several inflammatory cytokines and oxidative stresses are involved in the <clueType>pathogenesis</clueType> <linkTheme>of</linkTheme> HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event id="E5">
<type class="Regulation" />
<theme idref="A12" />
<cause idref="A2" />
<clue>As several inflammatory cytokines and oxidative stresses are <clueType>involved</clueType> <linkTheme>in</linkTheme> the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="E7" />
<cause idref="T14" />
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-<clueType>induced</clueType> HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="E7" />
<cause idref="T14" />
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-<clueType>induced</clueType> HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event id="E7">
<type class="Viral_life_cycle" />
<theme idref="A3" />
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 <clueType>replication</clueType> <clueLoc>in chronically infected cell lines</clueLoc>.</clue>
</event>
<event uncertainty="doubtful" id="E8">
<type class="Negative_regulation" />
<theme idref="E38" />
<cause idref="T12" />
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we investigated the <clueType>inhibitory effects</clueType> <linkCause>of</linkCause> cepharanthine <linkTheme>on</linkTheme> tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event uncertainty="doubtful" id="E9">
<type class="Negative_regulation" />
<theme idref="E6" />
<cause idref="T12" />
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we investigated the <clueType>inhibitory effects</clueType> <linkCause>of</linkCause> cepharanthine <linkTheme>on</linkTheme> tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<sentence id="S4">Two <term sem="Cell_cultured" id="T17" lex="chronically_HIV-1-infected_cell_line">chronically <term sem="Virus" id="T18" lex="HIV-1">HIV-1</term>-infected cell lines</term>, <term sem="Cell_cultured" id="T19" lex="U1">U1</term> (monocytic) and <term sem="Cell_cultured" id="T20" lex="ACH-2">ACH-2</term> (T lymphocytic), were stimulated with <term sem="Protein_molecule" id="T21" lex="TNF-alpha">TNF-alpha</term> or <term sem="Organic_compound_other" id="T22" lex="PMA">PMA</term> and cultured in the presence of various concentrations of the compound.</sentence>
<event id="E10">
<type class="Physiological_process" />
<theme idref="T19" />
<cause idref="T21" />
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were <clueType>stimulated</clueType> <linkCause>with</linkCause> TNF-alpha or PMA and cultured in the presence of various concentrations of the compound.</clue>
</event>
<event id="E11">
<type class="Physiological_process" />
<theme idref="T20" />
<cause idref="T21" />
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were <clueType>stimulated</clueType> <linkCause>with</linkCause> TNF-alpha or PMA and cultured in the presence of various concentrations of the compound.</clue>
</event>
<event id="E12">
<type class="Physiological_process" />
<theme idref="T19" />
<cause idref="T22" />
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were <clueType>stimulated</clueType> <linkCause>with</linkCause> TNF-alpha or PMA and cultured in the presence of various concentrations of the compound.</clue>
</event>
<event id="E13">
<type class="Physiological_process" />
<theme idref="T20" />
<cause idref="T22" />
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were <clueType>stimulated</clueType> <linkCause>with</linkCause> TNF-alpha or PMA and cultured in the presence of various concentrations of the compound.</clue>
</event>
<event id="E34">
<type class="Artificial_process" />
<theme idref="E10" />
<theme idref="T12" />
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were stimulated with TNF-alpha or PMA and <clueType>cultured</clueType> <linkTheme>in the presence of</linkTheme> various concentrations of <corefTheme>the compound</corefTheme>.</clue>
</event>
<event id="E35">
<type class="Artificial_process" />
<theme idref="E11" />
<theme idref="T12" />
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were stimulated with TNF-alpha or PMA and <clueType>cultured</clueType> <linkTheme>in the presence of</linkTheme> various concentrations of <corefTheme>the compound</corefTheme>.</clue>
</event>
<event id="E36">
<type class="Artificial_process" />
<theme idref="E12" />
<theme idref="T12" />
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were stimulated with TNF-alpha or PMA and <clueType>cultured</clueType> <linkTheme>in the presence of</linkTheme> various concentrations of <corefTheme>the compound</corefTheme>.</clue>
</event>
<event id="E37">
<type class="Artificial_process" />
<theme idref="E13" />
<theme idref="T12" />
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were stimulated with TNF-alpha or PMA and <clueType>cultured</clueType> <linkTheme>in the presence of</linkTheme> various concentrations of <corefTheme>the compound</corefTheme>.</clue>
</event>
<sentence id="S5"><term sem="Other" id="T23" lex="HIV-1_replication"><term sem="Virus" id="T24" lex="HIV-1">HIV-1</term> replication</term> was determined by <term sem="Other" id="T25" lex="p24_antigen_level"><term sem="Protein_molecule" id="T26" lex="p24_antigen">p24 antigen</term> level</term>.</sentence>
<event id="E14">
<type class="Viral_life_cycle" />
<theme idref="T24" />
<clue>HIV-1 <clueType>replication</clueType> was determined by p24 antigen level.</clue>
</event>
<event uncertainty="doubtful" id="E33">
<type class="Gene_expression" />
<theme idref="T25" />
<clue>HIV-1 replication was determined by p24 antigen <clueType>level</clueType>.</clue>
</event>
<sentence id="S6">The inhibitory effects of <term sem="Organic_compound_other" id="T27" lex="cepharanthine">cepharanthine</term> on <term sem="DNA_domain_or_region" id="T29" lex="HIV-1_long_terminal_repeat"><term sem="Virus" id="T30" lex="HIV-1">HIV-1</term> long terminal repeat</term> (<term sem="DNA_domain_or_region" id="T31" lex="LTR">LTR</term>)-driven <term sem="Other" id="A10">gene expression</term> and <term sem="Other" id="T32" lex="nuclear_factor_kappaB_(NF-kappaB)_activation"><term sem="Protein_complex" id="T33" lex="nuclear_factor_kappaB">nuclear factor kappaB</term> (<term sem="Protein_complex" id="T34" lex="NF-kappaB">NF-kappaB</term>) activation</term> were also examined.</sentence>
<event uncertainty="doubtful" id="E15">
<type class="Negative_regulation" />
<theme idref="E17" />
<cause idref="T27" />
<clue>The <clueType>inhibitory effects</clueType> <linkCause>of</linkCause> cepharanthine <linkTheme>on</linkTheme> HIV-1 long terminal repeat (LTR)-driven gene expression and nuclear factor kappaB (NF-kappaB) activation were also examined.</clue>
</event>
<event uncertainty="doubtful" id="E16">
<type class="Negative_regulation" />
<theme idref="E18" />
<cause idref="T27" />
<clue>The <clueType>inhibitory effects</clueType> <linkCause>of</linkCause> cepharanthine <linkTheme>on</linkTheme> HIV-1 long terminal repeat (LTR)-driven gene expression and nuclear factor kappaB (NF-kappaB) activation were also examined.</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="A10" />
<cause idref="T31" />
<clue>The inhibitory effects of cepharanthine on HIV-1 long terminal repeat (LTR)-<clueType>driven</clueType> gene expression and nuclear factor kappaB (NF-kappaB) activation were also examined.</clue>
<comment>NER: T28 del &quot;HIV-1 long terminal repeat (LTR)-driven gene expression&quot;</comment>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="T34" />
<clue>The inhibitory effects of cepharanthine on HIV-1 long terminal repeat (LTR)-driven gene expression and nuclear factor kappaB (NF-kappaB) <clueType>activation</clueType> were also examined.</clue>
</event>
<sentence id="S7"><term sem="Organic_compound_other" id="T35" lex="cepharanthine">Cepharanthine</term> dose dependently inhibited <term sem="Other" id="T36" lex="HIV-1_replication"><term sem="Virus" id="T37" lex="HIV-1">HIV-1</term> replication</term> in <cons sem="(AND Cell_cultured Cell_cultured)" id="T38" lex="(AND TNF-alpha-stimulated_U1_cell PMA-stimulated_U1_cell)"><frag id="F4"><term sem="Protein_molecule" id="A4">TNF-alpha</term>-</frag> and <frag id="F5"><term sem="Organic_compound_other" id="A5">PMA</term>-</frag><frag id="F6">stimulated <term sem="Cell_cultured" id="A6">U1 cells</term></frag></cons> but not in <term sem="Cell_cultured" id="T39" lex="ACH-2_cell">ACH-2 cells</term>.</sentence>
<event id="E19">
<type class="Viral_life_cycle" />
<theme idref="T37" />
<clue>Cepharanthine dose dependently inhibited HIV-1 <clueType>replication</clueType> in TNF-alpha- and PMA-stimulated U1 cells but not in ACH-2 cells.</clue>
</event>
<event id="E20">
<type class="Negative_regulation" />
<theme idref="E19" />
<cause idref="T35" />
<clue>Cepharanthine dose dependently <clueType>inhibited</clueType> HIV-1 replication <clueLoc>in TNF-alpha-</clueLoc> and PMA-<clueLoc>stimulated U1 cells</clueLoc> but not in ACH-2 cells.</clue>
</event>
<event id="E39">
<type class="Negative_regulation" />
<theme idref="E19" />
<cause idref="T35" />
<clue>Cepharanthine dose dependently <clueType>inhibited</clueType> HIV-1 replication <clueLoc>in</clueLoc> TNF-alpha- and <clueLoc>PMA-stimulated U1 cells</clueLoc> but not in ACH-2 cells.</clue>
</event>
<event assertion="non-exist" id="E21">
<type class="Negative_regulation" />
<theme idref="E19" />
<cause idref="T35" />
<clue>Cepharanthine dose dependently <clueType>inhibited</clueType> HIV-1 replication in TNF-alpha- and PMA-stimulated U1 cells but not <clueLoc>in ACH-2 cells</clueLoc>.</clue>
</event>
<event id="E22">
<type class="Physiological_process" />
<theme idref="A6" />
<cause idref="A4" />
<clue>Cepharanthine dose dependently inhibited HIV-1 replication in TNF-alpha- and PMA-<clueType>stimulated</clueType> U1 cells but not in ACH-2 cells.</clue>
</event>
<event id="E23">
<type class="Physiological_process" />
<theme idref="A6" />
<cause idref="A5" />
<clue>Cepharanthine dose dependently inhibited HIV-1 replication in TNF-alpha- and PMA-<clueType>stimulated</clueType> U1 cells but not in ACH-2 cells.</clue>
</event>
<sentence id="S8">Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in <term sem="Cell_cultured" id="T40" lex="PMA-stimulated_U1_cell"><term sem="Organic_compound_other" id="T41" lex="PMA">PMA</term>-stimulated <term sem="Cell_cultured" id="A7">U1 cells</term></term>, respectively.</sentence>
<event id="E24">
<type class="Physiological_process" />
<theme idref="A7" />
<cause idref="T41" />
<clue>Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-<clueType>stimulated</clueType> U1 cells, respectively.</clue>
</event>
<sentence id="S9"><term sem="Organic_compound_other" id="T42" lex="cepharanthine">Cepharanthine</term> was found to suppress <term sem="DNA_domain_or_region" id="T44" lex="HIV-1_LTR"><term sem="Virus" id="T45" lex="HIV-1">HIV-1</term> LTR</term>-driven <term sem="Other" id="A11">gene expression</term> through the inhibition of <term sem="Other" id="T46" lex="NF-kappaB_activation"><term sem="Protein_complex" id="T47" lex="NF-kappaB">NF-kappaB</term> activation</term>.</sentence>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E26" />
<cause idref="T42" />
<clue>Cepharanthine was found to suppress HIV-1 LTR-driven gene expression through the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappaB activation.</clue>
</event>
<event id="E26">
<type class="Positive_regulation" />
<theme idref="T47" />
<clue>Cepharanthine was found to suppress HIV-1 LTR-driven gene expression through the inhibition of NF-kappaB <clueType>activation</clueType>.</clue>
</event>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E28" />
<cause idref="E25" />
<clue>Cepharanthine was found to <clueType>suppress</clueType> HIV-1 LTR-driven gene expression <linkCause>through</linkCause> the inhibition of NF-kappaB activation.</clue>
</event>
<event id="E28">
<type class="Positive_regulation" />
<theme idref="A11" />
<cause idref="T44" />
<clue>Cepharanthine was found to suppress HIV-1 LTR-<clueType>driven</clueType> gene expression through the inhibition of NF-kappaB activation.</clue>
<comment>NER: T43 del &quot;HIV-1 LTR-driven gene expression&quot;</comment>
</event>
<sentence id="S10">These results indicate that <term sem="Organic_compound_other" id="T48" lex="cepharanthine">cepharanthine</term> is a highly potent inhibitor of <term sem="Other" id="T49" lex="HIV-1_replication"><term sem="Virus" id="T50" lex="HIV-1">HIV-1</term> replication</term> in a <term sem="Cell_cultured" id="T51" lex="chronically_infected_monocytic_cell_line">chronically infected <term sem="Cell_cultured" id="A8">monocytic cell line</term></term>.</sentence>
<event id="E29">
<type class="Viral_life_cycle" />
<theme idref="T50" />
<clue>These results indicate that cepharanthine is a highly potent inhibitor of HIV-1 <clueType>replication</clueType> <clueLoc>in a chronically infected monocytic cell line</clueLoc>.</clue>
</event>
<event id="E30">
<type class="Initiation_of_viral_infection" />
<theme idref="A8" />
<theme idref="T50" />
<clue>These results indicate that cepharanthine is a highly potent inhibitor of HIV-1 replication in a chronically <clueType>infected</clueType> monocytic cell line.</clue>
</event>
<event id="E31">
<type class="Negative_regulation" />
<theme idref="E29" />
<cause idref="T48" />
<clue>These results indicate that cepharanthine is a highly potent <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> HIV-1 replication <clueLoc>in a chronically infected monocytic cell line</clueLoc>.</clue>
</event>
<sentence id="S11">Since <term sem="Organic_compound_other" id="T52" lex="biscoclaurine_alkaloid">biscoclaurine alkaloids</term>, containing <term sem="Organic_compound_other" id="T53" lex="cepharanthine">cepharanthine</term> as a major component, are widely used for the treatment of patients with various <term sem="Other" id="T54" lex="inflammatory_disease">inflammatory diseases</term> in Japan, <term sem="Organic_compound_other" id="T55" lex="cepharanthine">cepharanthine</term> should be further pursued for its <term sem="Other" id="T56" lex="chemotherapeutic_potential">chemotherapeutic potential</term> in <term sem="Multicellular_organism_natural" id="T57" lex="HIV-1-infected_patient"><term sem="Virus" id="T58" lex="HIV-1">HIV-1</term>-infected <term sem="Multicellular_organism_natural" id="A9">patients</term></term>.</sentence>
<event id="E32">
<type class="Initiation_of_viral_infection" />
<theme idref="A9" />
<theme idref="T58" />
<clue>Since biscoclaurine alkaloids, containing cepharanthine as a major component, are widely used for the treatment of patients with various inflammatory diseases in Japan, cepharanthine should be further pursued for its chemotherapeutic potential in HIV-1-<clueType>infected</clueType> patients.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
